» Articles » PMID: 27929040

Involvement of P2X7 Receptor in Neuronal Degeneration Triggered by Traumatic Injury

Overview
Journal Sci Rep
Specialty Science
Date 2016 Dec 9
PMID 27929040
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Axonal injury is a common feature of central nervous system insults that culminates with the death of the affected neurons, and an irreversible loss of function. Inflammation is an important component of the neurodegenerative process, where the microglia plays an important role by releasing proinflammatory factors as well as clearing the death neurons by phagocytosis. Here we have identified the purinergic signaling through the P2X7 receptor as an important component for the neuronal death in a model of optic nerve axotomy. We have found that in P2X7 receptor deficient mice there is a delayed loss of retinal ganglion cells and a decrease of phagocytic microglia at early times points after axotomy. In contralateral to the axotomy retinas, P2X7 receptor controlled the numbers of phagocytic microglia, suggesting that extracellular ATP could act as a danger signal activating the P2X7 receptor in mediating the loss of neurons in contralateral retinas. Finally, we show that intravitreal administration of the selective P2X7 receptor antagonist A438079 also delays axotomy-induced retinal ganglion cell death in retinas from wild type mice. Thus, our work demonstrates that P2X7 receptor signaling is involved in neuronal cell death after axonal injury, being P2X7 receptor antagonism a potential therapeutic strategy.

Citing Articles

Retinal response to systemic inflammation differs between sexes and neurons.

Rodriguez-Ramirez K, Norte-Munoz M, Lucas-Ruiz F, Gallego-Ortega A, Calzaferri F, Garcia-Bernal D Front Immunol. 2024; 15:1340013.

PMID: 38384465 PMC: 10880026. DOI: 10.3389/fimmu.2024.1340013.


Mitochondrial Dysfunction and Apoptosis in Brain Microvascular Endothelial Cells Following Blast Traumatic Brain Injury.

Schmitt R, Qayum S, Pliss A, Kuzmin A, Muthaiah V, Kaliyappan K Cell Mol Neurobiol. 2023; 43(7):3639-3651.

PMID: 37314617 PMC: 11409997. DOI: 10.1007/s10571-023-01372-2.


Gene-agnostic therapeutic approaches for inherited retinal degenerations.

John M, Quinn J, Hu M, Cehajic-Kapetanovic J, Xue K Front Mol Neurosci. 2023; 15:1068185.

PMID: 36710928 PMC: 9881597. DOI: 10.3389/fnmol.2022.1068185.


GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target.

Hottin C, Perron M, Roger J Cells. 2022; 11(18).

PMID: 36139472 PMC: 9496697. DOI: 10.3390/cells11182898.


Fractalkine/CXCR Pathway in Neuropathic Pain: An Update.

Silva R, Malcangio M Front Pain Res (Lausanne). 2022; 2:684684.

PMID: 35295489 PMC: 8915718. DOI: 10.3389/fpain.2021.684684.


References
1.
Nadal-Nicolas F, Jimenez-Lopez M, Salinas-Navarro M, Sobrado-Calvo P, Alburquerque-Bejar J, Vidal-Sanz M . Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats. PLoS One. 2012; 7(11):e49830. PMC: 3500320. DOI: 10.1371/journal.pone.0049830. View

2.
Vidal-Sanz M, Valiente-Soriano F, Ortin-Martinez A, Nadal-Nicolas F, Jimenez-Lopez M, Salinas-Navarro M . Retinal neurodegeneration in experimental glaucoma. Prog Brain Res. 2015; 220:1-35. DOI: 10.1016/bs.pbr.2015.04.008. View

3.
Jimenez-Pacheco A, Mesuret G, Sanz-Rodriguez A, Tanaka K, Mooney C, Conroy R . Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079. Epilepsia. 2013; 54(9):1551-61. DOI: 10.1111/epi.12257. View

4.
Kakurai K, Sugiyama T, Kurimoto T, Oku H, Ikeda T . Involvement of P2X(7) receptors in retinal ganglion cell death after optic nerve crush injury in rats. Neurosci Lett. 2012; 534:237-41. DOI: 10.1016/j.neulet.2012.11.060. View

5.
Ramirez A, Salazar J, de Hoz R, Rojas B, Gallego B, Salobrar-Garcia E . Macro- and microglial responses in the fellow eyes contralateral to glaucomatous eyes. Prog Brain Res. 2015; 220:155-72. DOI: 10.1016/bs.pbr.2015.05.003. View